Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AirGOs-medical: ASA Desensitization in CRSwNP
NCT03825757Completed
- Start
- Jan 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Primaspan with Placebo (2 arms). Primary endpoint: Change in Endoscopic Nasal Polyp Score at 11 months. Started Jan 2019; status: completed.
02
Drugs
Cartia
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT03825757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03825757.